Gastrointestinal Cancer News

MRI screening effectively detected pancreatic lesions in patients at an elevated risk for pancreatic cancer, according to results of a prospective observational study.

Nomograms effectively predicted the risks for gastrointestinal stromal tumor progression and death and may be valuable for risk stratification and patient counseling, according to study results.

Percutaneous hepatic perfusion increased hepatic progression free and overall survival rates in patients with liver metastases from melanoma vs. patients who underwent yttrium-90 therapy, according to data presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.

Patients with rectal cancer demonstrated comparable rates of locoregional recurrence, DFS and OS when they underwent laparoscopic or open surgery, according to study results.

The American Gastroenterological Association has released a new guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts, which recommends some significant changes regarding surveillance periods and surgery.

In a retrospective study, researchers used Caris Molecular Intelligence to identify molecular patterns and therapeutic options for hepatocellular carcinoma and presented the data at the 68th Annual Cancer Symposium of the Society of Surgical Oncology in Houston, according to a news release.

Middle-aged men with a high cardiorespiratory fitness level displayed decreased risks for lung and colon cancers, as well as a decreased risk for cancer-related death if diagnosed later in life, according to results of a prospective, observational analysis.

In a phase 2 clinical trial, antineoplastons, such as A10 injection and AS2-1, were a useful form of adjunctive therapy after hepatic arterial infusion, and improved cancer-specific survival in patients with liver metastases from colorectal cancer, according to study data.

Parenchymal preservation reduced mortality rate and complications in patients who underwent hepatectomy for malignancies, according to newly published data. 

The Removing Barriers to Colorectal Cancer Screening Act (H.R. 1220 and S. 624) was introduced in the House and Senate this month, according to a press release.